Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
American family trapped by wildfire raging in France as another heat wave looms over Western Europe
Along France's southern Atlantic coast,...
Child drowns at Brantley Lake in Eddy County
EDDY COUNTY, N.M. (KRQE) – A child drowned at Brantley...
Megan Moroney Reveals a Hidden Talent Nobody Knew About
Megan Moroney recently sat down with Cosmopolitan for a wide-ranging interview...
Cracker Barrel CEO Stepping Down After Logo Controversy, Activist Pressure
Cracker Barrel said Chief Executive Julie Masino is stepping...